Oslo - Delayed Quote NOK

PCI Biotech Holding ASA (PCIB.OL)

1.7600

-0.1000

(-5.38%)

At close: May 16 at 4:10:02 PM GMT+2

Notice of Annual General Meeting 2025

Oslo, Norway, 30 April 2025 - The annual general meeting of PCI Biotech Holding ASA will be held at the company’s office at Oslo Cancer Cluster Innovation Park on 22 May 2025 at 10:00am (CEST). The notice and proposed resolutions to the annual general meeting are attached. The notice, including all appendices, will be made available at PCI Biotech's corporate website www.pcibiotech.com. For further information, please contact: Ronny Skuggedal, CEO/CFO, E-mail: rs@pcibiotech.noOffice: +47 67 11 5

GlobeNewswire 17 days ago

PCIB.OL
-5.38%
PCI Biotech full year 2024 interim results

Oslo (Norway), 27 February 2025 – PCI Biotech (OSE: PCIB), today announces its preliminary full year 2024 results. Please find enclosed the interim report and presentation. Highlights review OperationsPCI Biotech’s 2024 development goals were to demonstrate scalability and manufacturing process benefits of the photochemical-based technology (PCL) in viral vector (AAV) manufacturing by advancing the technology into mini benchtop bioreactors, which are considered representative for commercial manu

GlobeNewswire 2 months ago

PCIB.OL
-5.38%
PCI Biotech: Invitation to preliminary full-year 2024 results presentation

Oslo, Norway, 25 February 2025 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's full-year 2024 interim report on Thursday 27 February 2025, 08:30am – 09:00am CET (local time). The presentation will be held as a live webcast available through www.pcibiotech.com. The presentation will be held in Norwegian. There will be a Q&A session at the end of the presentation and it will be possible to post written questions through the webcast console. The interim report and prese

GlobeNewswire 2 months ago

PCIB.OL
-5.38%
PCI Biotech: Employee share option scheme in connection with promotion of new CSO

Oslo, 10 January 2025 - PCI Biotech (OSE: PCIB), today announced that the Board of Directors has granted share options to Morten Luhr who has been promoted to Chief Scientific Officer (CSO) from January 2025. Anders Høgset, former CSO, will commence as Scientific Advisor in a 20% position. In accordance with the authorisation granted by the Annual General Meeting 24 May 2024 and the remuneration policy adopted by the Annual General Meeting 28 May 2021, the Board of Directors of PCI Biotech Holdi

GlobeNewswire 4 months ago

PCIB.OL
-5.38%
PCI Biotech: Employee share option scheme

Oslo, 2 September 2024 - PCI Biotech (OSE: PCIB), today announce that the Board of Directors has granted share options to key employees. In accordance with the authorisation granted by the Annual General Meeting 24 May 2024 and the remuneration policy adopted by the Annual General Meeting 28 May 2021, the Board of Directors of PCI Biotech Holding ASA (“PCI Biotech”) has awarded a total of 885,000 share options to key employees. Each share option gives the right to subscribe for or acquire one sh

GlobeNewswire 8 months ago

PCIB.OL
-5.38%
PCI Biotech first half 2024 interim results

Oslo (Norway), 28 August 2024 – PCI Biotech (OSE: PCIB), today announces its interim first half 2024 results. Please find enclosed the interim report and presentation.Highlights review OperationsPCI Biotech’s 2024 development goals are to demonstrate scalability and manufacturing process benefits for the photochemical-based technology (PCL) in viral vector manufacturing. Results reported in Q1 2024 from field testing of the technology with a European partner confirmed the potential benefit of ap

GlobeNewswire 8 months ago

PCIB.OL
-5.38%
PCI Biotech: Invitation to first half interim 2024 results presentation

Oslo, Norway, 23 August 2024 - PCI Biotech (OSE: PCIB) invites to a webcast presentation of the company's first half 2024 interim report on Wednesday 28 August 2024, 08:30am – 09:00am CEST (local time). The presentation will be held as a live webcast available through www.pcibiotech.com. The presentation will be held in Norwegian. There will be a Q&A session at the end of the presentation and it will be possible to post written questions through the webcast console. The interim report and presen

GlobeNewswire 8 months ago

PCIB.OL
-5.38%
Disclosure of voting rights for Chair of the Board

Oslo, 23 May 2024. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of Hans Peter Bøhn, Chair of the Board of Directors. Hans Peter Bøhn is chair of PCI Biotech’s board of directors and shall open the annual general meeting of the Company on 24 May 2024. Mr. Bøhn holds 123,662 shares, representing 0.3 percent of the share capital of PCI Biotech. Mr. Bøhn has received powers of attorney to represent and vote for 4,288,185 additional shares. In total, Mr.

GlobeNewswire 11 months ago

PCIB.OL
-5.38%

Performance Overview

Return	PCIB.OL	OBX Total Return Index (OBX.OL)
YTD	+48.15%	+11.38%
1-Year	+7.98%	+11.62%
3-Year	-60.36%	+33.07%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

PCI Biotech Holding ASA (PCIB.OL)

Notice of Annual General Meeting 2025

PCI Biotech full year 2024 interim results

PCI Biotech: Invitation to preliminary full-year 2024 results presentation

PCI Biotech: Employee share option scheme in connection with promotion of new CSO

PCI Biotech: Employee share option scheme

PCI Biotech first half 2024 interim results

PCI Biotech: Invitation to first half interim 2024 results presentation

Disclosure of voting rights for Chair of the Board

Performance Overview